Welcome Guest
Home > Clinical Breast Cancer > Volume 7 |  Issue 7 > Article Abstract

Abstract
Back to TOC
References
X

Note:- Read as Author : Article Title : Source : Year : Publisher

    1.  Lee JJ, Swain SM. Development of novel chemotherapeutic agents to evade the mechanisms of multidrug resistance (MDR). Semin Oncol 2005; 32:S22-S26.
    2.  Jordan MA, Miller H, Ni L, et al. The Pat-21 breast cancer model derived from a patient with primary Taxol(r) resistance recapitulates the phenotype of its origin, has alteredβ-tubulin expression and is sensitive to ixabepilone. Proc Am Assoc Cancer Res 2006; 47:21-21.
    3.  Borzilleri R, Fairchild CR, Lee FY, Lee FYF, et al. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy. Clin Cancer Res 2001; 7:1429-1437.
    4.  Bode C, Gupta ML Jr, Rieff EA, et al. Epothilone and paclitaxel: unexpected differences in promoting the assembly and stabilisation of yeast microtubules. Biochemistry 2002; 41:3870-3874.
    5.  Brooks TA, Minderman H, O'Loughlin KL, et al. Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. Mol Cancer Ther 2003; 2:1195-1205.
    6.  Aghajanian C, Burris HA III, Jones S, et al. Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas. J Clin Oncol 2007; 25:1082-1088.
    7.  Dickson N, Peck R, Wu C, et al. Ixabepilone given weekly in patients with advanced malignancies: final efficacy and safety results of a phase I trial. J Clin Oncol 2006; 24((18 suppl)):89s-89s.
    8.  Denduluri N, Lee JJ, Walshe JM, et al. Phase II clinical trial of ixabepilone in metastatic breast cancer (MBC) patients previously untreated with taxanes. J Clin Oncol 2006; 24((18 suppl)):40s-40s.
    9.  Conte P, Martin M, Thomas E, et al. Phase II study of ixabepilone in patients (pts) with taxane-resistant metastatic breast cancer (MBC): final report. J Clin Oncol 2006; 24((18 suppl)):568s-568s.
    10.  Mukhopadhyay P, Perez EA, Thomas E, et al. Phase II trial of ixabepilone in patients with metastatic breast cancer (MBC) who are resistant to an anthracycline, a taxane and capecitabine. J Clin Oncol 2006; 24(18 suppl):42s-42s.
    11.  Lerzo G, Pivot X, Thomas E, et al. Ixabepilone in patients with metastatic breast cancer who are resistant to an anthracycline, a taxane and capecitabine. Presented at: 31st European Society of Medical Oncology Congress; September 29-October 3, 2006; Istanbul, Turkey.
    12.  Baselga J, Llombart Cussac A, Manikhas G, et al. Phase II genomics study in patients receiving ixabepilone as neoadjuvant treatment for breast-cancer (BC): preliminary efficacy and safety data. J Clin Oncol 2005; 23((16 suppl)):25s-25s.
    13.  Asmar L, Buzdar AU, Pivot X, et al. A unified definition of clinical anthracycline resistance breast cancer. Br J Cancer 2000; 82:529-534.
    14.  Bunnell CA, Klimovsky J, Thomas E, et al. Final efficacy results of a phase I/II trial of ixabepilone in combination with capecitabine in patients with metastatic breast cancer (MBC) previously treated with a taxane and an anthracycline. J Clin Oncol 2006; 24(18 suppl):568s-568s.
    15.  Colevas AD, Posadas EM, Undevia S, et al. A phase II study of ixabepilone (BMS 247550) in metastatic renal cell carcinoma. J Clin Oncol 2006; 24(18 suppl):648s-648s.
    16.  McCoy SA, Rivkin SE, Whitehead RP, et al. A phase II trial of epothilone B analogue BMS-247550 (NSC #710428) in patients with advanced pancreas cancer: a Southwest Oncology Group study. J Clin Oncol 2004; 22:315-315.
    17.  Breton J-L, Sandler A, Vansteenkiste JF, et al. A randomized phase II study of epothilone analog BMS-247550 in patients (pts) with non-small cell lung cancer (NSCLC) who have failed first-line platinum-based chemotherapy. J Clin Oncol 2003; 22:626-626.
    18.  Lin AM, Rosenberg JE, Weinberg VK, et al. Clinical outcome of taxane-resistant (TR) hormone refractory prostate cancer (HRPC) patients (pts) treated with subsequent chemotherapy (ixabepilone (Ix) or mitoxantrone/prednisone (MP). J Clin Oncol 2006; 24(18 suppl):231s-231s.
    19.  Hussain M, Lara PN Jr, Tangen CM, et al. Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111. J Clin Oncol 2005; 23:8724-8729.
E-mail this article
X

Fields marked with an asterisk * are mandatory.

* Your Name:
* Your Email:
* Friend's Name:
* Friend's Email:
Message:
 
Send CC to self
 
 
Add to Favorites
X
  • Volume 7
  •  Issue 7
    • Publication Date: April 2007


Efficacy and Safety of Ixabepilone, a Novel Epothilone Analogue


Xavier Pivot, Armelle Dufresne, Christian Villanueva

The epothilones and their analogues are a new class of anticancer agents derived from the fermentation of myxobacterium Sorangium cellulosum. These compounds have some similarities to taxanes in targeting and stabilizing microtubules, but they also have important differences. Among the epothilone family, ixabepilone has emerged to be a semisynthetic epothilone analogue of interest. Ixabepilone has demonstrated consistent preclinical activity and seems active against various taxane-sensible and taxane-resistant cell lines, including those with overexpression of multidrug resistance and with mutations in the β-tubulin gene. The interest of this ixabepilone has been confirmed clinically. Phase II clinical studies have demonstrated high activity in patients with taxane-resistant metastatic breast cancer and in patients with other chemotherapy-resistant tumor types.

Key words: Anthracyclines, Neuropathy, Neurotoxicity, Taxanes, Toxicity


  1. https://www.ceteresopolitano.org/
  2. https://www.crossingstoronto.com/
  3. https://www.jediism.org/
  4. https://www.badenumc.org/
  5. https://www.johnsevierchapter.org/
  6. https://www.trinitychapelmn.org/
  7. https://www.photogearnews.com/
  8. https://www.alz-nova.org/
  9. https://www.cigjournals.com/
  10. https://summa-edu.com/
  11. https://cpawilmingtonnc.org/
  12. https://bimometals.com/
  13. https://sosenvironmental.com/
  14. https://thefriary.org/
  15. https://post5theatre.org/
  1. KELUARAN SGP
  2. TOGEL